Cite
HARVARD Citation
Lara, P. et al. (n.d.). 801PBone metabolism biomarkers (BMB) in hormone sensitive prostate cancer (HSPC): Results from SWOG S1216, a phase III trial of androgen deprivation therapy (ADT) +/- orteronel. Annals of oncology. p. . [Online].